A detailed history of Tru North Capital Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Tru North Capital Management, LLC holds 24 shares of NVS stock, worth $2,555. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24
Holding current value
$2,555
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 17, 2024

BUY
$95.27 - $108.47 $2,286 - $2,603
24 New
24 $2.32 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $229B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Tru North Capital Management, LLC Portfolio

Follow Tru North Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tru North Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tru North Capital Management, LLC with notifications on news.